{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:32:36Z","timestamp":1791977556097,"version":"4.4.0"},"reference-count":69,"publisher":"Journal of Biological Methods","issue":"5","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HPR"],"abstract":"<jats:p>A migraine is a clinical diagnosis with a presentation of one or more severe unilateral or bilateral headache(s) often preceded by an aura and typically accompanied by nausea, vomiting, photophobia, and\/or phonophobia. This neurological disease is often debilitating and greatly affects the quality of life of those it inflicts. In fact, a recent study conducted by the Global Burden of Disease and published in The Lancet Neurology revealed that migraines ranked second to only back pain as the most disabling disease. Triggers for migraines have ranged from female sex, low socioeconomic status, and diet to loud noises, sleep hygiene, and stress. Along with its clinical presentation, laboratory tests and imaging help rule out other potential causes of the headache and lead to a diagnosis of migraine. Migraines are typically divided into three phases: prodromal, headache, and postdrome. The pathophysiology of each phase remains under investigation, with differing theories regarding their pathways. Existing therapies are abortive therapies for acute migraines or preventative therapies. Abortive therapy consists of NSAIDs and triptans. Preventative therapies include tricyclic antidepressants, calcium channel blockers, beta-blockers, and anticonvulsants. In this review, we focus on the role of NSAIDs and the COX-2 inhibitor, celecoxib oral solution, for the abortive treatment of acute migraines.<\/jats:p>","DOI":"10.52965\/001c.34265","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T12:17:31Z","timestamp":1650975451000},"page":"1","source":"Crossref","is-referenced-by-count":2,"title":["A Comprehensive Review of Celecoxib Oral Solution for the Acute \u00a0 Treatment of Migraine"],"prefix":"10.14440","volume":"10","author":[{"given":"Nazir","family":"Noor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"LaChute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Root","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Urits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazih","family":"Khater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"D. Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5574","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/s0149-2918(00)80005-3","article-title":"Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis","volume":"21","author":"Marvin M. Goldenberg","year":"1999","journal-title":"Clinical Therapeutics","ISSN":"https:\/\/id.crossref.org\/issn\/0149-2918","issn-type":"print"},{"issue":"11","key":"ref2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/s1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Lars Jacob Stovner","year":"2018","journal-title":"The Lancet Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/1474-4422","issn-type":"print"},{"issue":"7","key":"ref3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States: Data from the American Migraine Study II","volume":"41","author":"Richard B. Lipton","year":"2001","journal-title":"Headache: The Journal of Head and Face Pain","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"issue":"1","key":"ref4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/s1474-4422(16)30293-9","article-title":"Sex differences in the epidemiology, clinical features, and pathophysiology of migraine","volume":"16","author":"Kjersti Gr\u00f8tta Vetvik","year":"2017","journal-title":"The Lancet Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/1474-4422","issn-type":"print"},{"issue":"7","key":"ref5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/0333102411398400","article-title":"Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: A systematic review","volume":"31","author":"Michel Lant\u00e9ri-Minet","year":"2011","journal-title":"Cephalalgia","ISSN":"https:\/\/id.crossref.org\/issn\/0333-1024","issn-type":"print"},{"issue":"5","key":"ref6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.mayocp.2016.02.013","article-title":"Impact of Migraine on the Family: Perspectives of People with Migraine and Their Spouse\/Domestic Partner in the CaMEO Study","volume":"91","author":"Dawn C. Buse","year":"2016","journal-title":"Mayo Clinic Proceedings","ISSN":"https:\/\/id.crossref.org\/issn\/0025-6196","issn-type":"print"},{"issue":"s1","key":"ref7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1526-4610.2005.4501001.x","article-title":"Migraine: Epidemiology, impact, and risk factors for progression","volume":"45","author":"Richard B. Lipton","year":"2005","journal-title":"Headache: The Journal of Head and Face Pain","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"issue":"1","key":"ref8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/head.12725","article-title":"Migraine Triggers and Oxidative Stress: A Narrative Review and Synthesis","volume":"56","author":"Jonathan M. Borkum","year":"2016","journal-title":"Headache: The Journal of Head and Face Pain","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00631.x","article-title":"Patterns of Diagnosis and Acute and Preventive Treatment for Migraine in the United States: Results from the American Migraine Prevalence and Prevention Study","author":"Seymour Diamond","year":"2006","journal-title":"Headache: The Journal of Head and Face Pain","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"issue":"12","key":"ref10","doi-asserted-by":"publisher","first-page":"41582","DOI":"10.1038\/s41582-018-0098-4","article-title":"Biological insights from the premonitory symptoms of migraine","volume":"14","author":"Nazia Karsan","year":"2018","journal-title":"Nature Reviews Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/1759-4758","issn-type":"print"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-015-0495-7","article-title":"Photo-, osmo- and phonophobia in the premonitory phase of migraine: Mistaking symptoms for triggers?","volume":"16","author":"Laura H Schulte","year":"2015","journal-title":"The Journal of Headache and Pain","ISSN":"https:\/\/id.crossref.org\/issn\/1129-2369","issn-type":"print"},{"issue":"2","key":"ref12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/0333102416683917","article-title":"When cervical pain is actually migraine: An observational study in 207 patients","volume":"38","author":"Michele Viana","year":"2016","journal-title":"Cephalalgia","ISSN":"https:\/\/id.crossref.org\/issn\/0333-1024","issn-type":"print"},{"issue":"2","key":"ref13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ncl.2008.11.009","article-title":"Diagnostic Testing for Migraine and Other Primary Headaches","volume":"27","author":"Randolph W. Evans","year":"2009","journal-title":"Neurologic Clinics","ISSN":"https:\/\/id.crossref.org\/issn\/0733-8619","issn-type":"print"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/head.13300","article-title":"A Phase-by-Phase Review of Migraine Pathophysiology","volume":"58","author":"David W. Dodick","year":"2018","journal-title":"Headache: The Journal of Head and Face Pain","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015.-Plaguing","article-title":"Pathophysiology of Migraine: A Disorder of Sensory Processing","volume":"97","author":"P.J. Goadsby","year":"2017","journal-title":"Physiol Rev"},{"issue":"9","key":"ref16","doi-asserted-by":"publisher","first-page":"00415","DOI":"10.1007\/s00415-017-8434-y","article-title":"An update on migraine: Current understanding and future directions","volume":"264","author":"Francesca Puledda","year":"2017","journal-title":"Journal of Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0340-5354","issn-type":"print"},{"issue":"10","key":"ref17","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/brain\/aww236","article-title":"Bench to bedside advances in the 21st century for primary headache disorders: Migraine treatments for migraine patients","volume":"139","author":"Peter J. Goadsby","year":"2016","journal-title":"Brain","ISSN":"https:\/\/id.crossref.org\/issn\/0006-8950","issn-type":"print"},{"issue":"5","key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd009865.pub2","article-title":"Celecoxib for osteoarthritis","volume":"2017","author":"Livia Puljak","year":"2017","journal-title":"Cochrane Database of Systematic Reviews","ISSN":"https:\/\/id.crossref.org\/issn\/1465-1858","issn-type":"print"},{"issue":"6","key":"ref19","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00296-011-2263-6","article-title":"A turbulent decade for NSAIDs: Update on current concepts of classification, epidemiology, comparative efficacy, and toxicity","volume":"32","author":"Philip G. Conaghan","year":"2012","journal-title":"Rheumatology International","ISSN":"https:\/\/id.crossref.org\/issn\/0172-8172","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.7556\/jaoa.1999.99.11.S13","article-title":"Celecoxib for the treatment of pain and inflammation: The preclinical and clinical results - PubMed","volume":"11 Suppl","author":"E. Tindall","year":"1999","journal-title":"J Am Osteopath"},{"issue":"7","key":"ref21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/0333102414552532","article-title":"The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results","volume":"35","author":"Aubrey Manack Adams","year":"2015","journal-title":"Cephalalgia","ISSN":"https:\/\/id.crossref.org\/issn\/0333-1024","issn-type":"print"},{"issue":"104872","key":"ref22","doi-asserted-by":"publisher","first-page":"104872","DOI":"10.1016\/j.fitote.2021.104872","article-title":"Discovery of cyclooxygenase-2 inhibitors from Kadsura coccinea by affinity ultrafiltration mass spectrometry and the anti-inflammatory activity","volume":"151","author":"Xiang-Yun Zhang","year":"2021","journal-title":"Fitoterapia","ISSN":"https:\/\/id.crossref.org\/issn\/0367-326X","issn-type":"print"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd012095.pub2","article-title":"Celecoxib for rheumatoid arthritis","author":"Antonia Jelicic Kadic","year":"2017","journal-title":"Cochrane Database of Systematic Reviews","ISSN":"https:\/\/id.crossref.org\/issn\/1465-1858","issn-type":"print"},{"issue":"4","key":"ref24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/fpc.0b013e32834f94cb","article-title":"Celecoxib pathways: Pharmacokinetics and pharmacodynamics","volume":"22","author":"Li Gong","year":"2012","journal-title":"Pharmacogenetics and genomics","ISSN":"https:\/\/id.crossref.org\/issn\/1744-6872","issn-type":"print"},{"issue":"12","key":"ref25","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1007\/s00132-003-0569-0","article-title":"Klinische Pharmakologie der selektiven COX-2-Hemmer","volume":"32","author":"M. Burian","year":"2003","journal-title":"Der Orthop\ufffdde","ISSN":"https:\/\/id.crossref.org\/issn\/0085-4530","issn-type":"print"},{"issue":"3","key":"ref26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2174\/1389450119666180803121737","article-title":"Celecoxib in Cancer Therapy and Prevention \u2013 Review","volume":"20","author":"Natalia To\u0142oczko-Iwaniuk","year":"2018","journal-title":"Current Drug Targets","ISSN":"https:\/\/id.crossref.org\/issn\/1389-4501","issn-type":"print"},{"key":"ref27","series-title":"The Essence of Analgesia and Analgesics","first-page":"238","article-title":"Celecoxib","author":"Joseph Marino","year":"2010"},{"issue":"106379","key":"ref28","doi-asserted-by":"publisher","first-page":"106379","DOI":"10.1016\/j.prostaglandins.2019.106379","article-title":"A journey of celecoxib from pain to cancer","volume":"147","author":"Pratiksha Saxena","year":"2020","journal-title":"Prostaglandins &amp; Other Lipid Mediators","ISSN":"https:\/\/id.crossref.org\/issn\/1098-8823","issn-type":"print"},{"issue":"9","key":"ref29","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/s0149-2918(00)80005-3","article-title":"Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis","volume":"21","author":"Marvin M. Goldenberg","year":"1999","journal-title":"Clinical Therapeutics","ISSN":"https:\/\/id.crossref.org\/issn\/0149-2918","issn-type":"print"},{"issue":"5","key":"ref30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1517\/13543784.6.5.609","article-title":"Selective cyclooxygenase-2 inhibitors: Pharmacology, clinical effects and therapeutic potential","volume":"6","author":"Joanne van Ryn","year":"1997","journal-title":"Expert opinion on investigational drugs","ISSN":"https:\/\/id.crossref.org\/issn\/1354-3784","issn-type":"print"},{"issue":"3","key":"ref31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2165\/00003088-200038030-00003","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib","volume":"38","author":"Neal M. Davies","year":"2000","journal-title":"Clinical Pharmacokinetics","ISSN":"https:\/\/id.crossref.org\/issn\/0312-5963","issn-type":"print"},{"issue":"11","key":"ref32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41582-019-0255-4","article-title":"The metabolic face of migraine \u2014 from pathophysiology to treatment","volume":"15","author":"Elena C. Gross","year":"2019","journal-title":"Nature Reviews Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/1759-4758","issn-type":"print"},{"issue":"3","key":"ref33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2165\/00003088-200038030-00003","article-title":"Clinical pharmacokinetics and pharmacodynamics of celecoxib: A selective cyclo-oxygenase-2 inhibitor","volume":"38","author":"Neal M. Davies","year":"2000","journal-title":"Clinical pharmacokinetics","ISSN":"https:\/\/id.crossref.org\/issn\/0312-5963","issn-type":"print"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","DOI":"10.1016\/S0090-9556(24)15366-4","article-title":"Metabolism and Excretion of [14C]Celecoxib in Healthy Male Volunteers","volume":"28","author":"S.K. Paulson","year":"2000","journal-title":"Drug Metabolism and Disposition"},{"issue":"5","key":"ref35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/ajhp\/56.5.403","article-title":"Celecoxib approved as NSAID with some concessions on class warning","volume":"56","author":"Jane L. Miller","year":"1999","journal-title":"American Journal of Health-System Pharmacy","ISSN":"https:\/\/id.crossref.org\/issn\/1079-2082","issn-type":"print"},{"issue":"3","key":"ref36","doi-asserted-by":"publisher","first-page":"R644","DOI":"10.1186\/ar1704","article-title":"Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: Systematic review and meta-analysis of information from company clinical trial reports","volume":"7","author":"R Andrew Moore","year":"2005","journal-title":"Arthritis Research &amp; Therapy","ISSN":"https:\/\/id.crossref.org\/issn\/1465-9905","issn-type":"print"},{"issue":"2","key":"ref37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/00912700022008766","article-title":"Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial","volume":"40","author":"Philip T. Leese","year":"2000","journal-title":"Journal of Clinical Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0091-2700","issn-type":"print"},{"issue":"3","key":"ref38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00045391-200007030-00004","article-title":"Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor","volume":"7","author":"A. Whelton","year":"2000","journal-title":"American Journal of Therapeutics","ISSN":"https:\/\/id.crossref.org\/issn\/1075-2765","issn-type":"print"},{"issue":"11","key":"ref39","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.4065\/74.11.1095","article-title":"Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial","volume":"74","author":"William G. Bensen","year":"1999","journal-title":"Mayo Clinic Proceedings","ISSN":"https:\/\/id.crossref.org\/issn\/0025-6196","issn-type":"print"},{"issue":"31","key":"ref40","doi-asserted-by":"publisher","first-page":"e11649","DOI":"10.1097\/md.0000000000011649","article-title":"Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis","volume":"97","author":"Xi-Tian Zhu","year":"2018","journal-title":"Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7974","issn-type":"print"},{"issue":"9","key":"ref41","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00402-015-2277-8","article-title":"Incidence and risk factors for heterotopic ossification after total hip arthroplasty: A meta-analysis","volume":"135","author":"Yanbin Zhu","year":"2015","journal-title":"Archives of Orthopaedic and Trauma Surgery","ISSN":"https:\/\/id.crossref.org\/issn\/0936-8051","issn-type":"print"},{"issue":"12","key":"ref42","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/bot.0b013e3182724624","article-title":"Heterotopic ossification in orthopaedic trauma","volume":"26","author":"Aaron Nauth","year":"2012","journal-title":"Journal of Orthopaedic Trauma","ISSN":"https:\/\/id.crossref.org\/issn\/0890-5339","issn-type":"print"},{"issue":"4","key":"ref43","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s40265-018-0865-y","article-title":"Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs","volume":"78","author":"Jonathan Jia Yuan Ong","year":"2018","journal-title":"Drugs","ISSN":"https:\/\/id.crossref.org\/issn\/0012-6667","issn-type":"print"},{"issue":"3","key":"ref44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10787-021-00792-0","article-title":"Efficiency and safety: Comparison between preoperative analgesia and postoperative analgesia using non-steroidal anti-inflammatory drugs in patients receiving arthroscopic knee surgery in a multicenter, randomized, controlled study","volume":"29","author":"Ling Ma","year":"2021","journal-title":"Inflammopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0925-4692","issn-type":"print"},{"issue":"7","key":"ref45","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1007\/s00595-020-02199-w","article-title":"Efficacy of celecoxib as preemptive analgesia for patients undergoing laparoscopic inguinal hernia repair: A randomized trial","volume":"51","author":"Takuya Saito","year":"2021","journal-title":"Surgery Today","ISSN":"https:\/\/id.crossref.org\/issn\/0941-1291","issn-type":"print"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2147\/ceor.s280556","article-title":"Evaluating the cost-effectiveness of celecoxib versus ibuprofen and naproxen in patients with osteoarthritis in united arab emirates based on the precision trial","volume":"13","author":"Viktor V Chirikov","year":"2021","journal-title":"ClinicoEconomics and Outcomes Research","ISSN":"https:\/\/id.crossref.org\/issn\/1178-6981","issn-type":"print"},{"issue":"5","key":"ref47","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.21037\/apm-21-590","article-title":"Clinical efficacy evaluation and prevention of adverse reactions in a randomized trial of a combination of three drugs in the treatment of cancerous pudendal neuralgia","volume":"10","author":"Junjie Hou","year":"2021","journal-title":"Annals of Palliative Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/2224-5820","issn-type":"print"},{"issue":"26","key":"ref48","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/nejmoa1611593","article-title":"Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis","volume":"375","author":"Steven E. Nissen","year":"2016","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"6","key":"ref49","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1056\/nejmoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention: Commentary","volume":"48","author":"S.A. Sgambati","year":"2005","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"13","key":"ref50","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2","volume":"296","author":"Patricia McGettigan","year":"2006","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"1","key":"ref51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/07853890601073445","article-title":"Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs","volume":"39","author":"Matthias Hermann","year":"2007","journal-title":"Annals of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0785-3890","issn-type":"print"},{"issue":"9","key":"ref52","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1345\/aph.18415","article-title":"The cyclooxygenase-2 inhibitors: Safety and effectiveness","volume":"33","author":"Barbara Kaplan-Machlis","year":"1999","journal-title":"Annals of Pharmacotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/1060-0280","issn-type":"print"},{"issue":"20","key":"ref53","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1001\/jama.282.20.1921","article-title":"Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial","volume":"282","author":"Lee S. Simon","year":"1999","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"8","key":"ref54","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1212\/wnl.58.8.1234","article-title":"Acute migraine headache","volume":"58","author":"H. Kaube","year":"2002","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"issue":"12","key":"ref55","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1046\/j.1365-2036.2002.01376.x","article-title":"Arthritis treatment in Hong Kong - Cost analysis of celecoxib versus conventional NSAIDS, with or without gastroprotective agents","volume":"16","author":"J. H. S. You","year":"2002","journal-title":"Alimentary Pharmacology & Therapeutics","ISSN":"https:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"issue":"12","key":"ref56","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1345\/aph.1a110","article-title":"Intracerebral hemorrhage following possible interaction between celecoxib and clopidogrel","volume":"35","author":"Alex A Fisher","year":"2001","journal-title":"Annals of Pharmacotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/1060-0280","issn-type":"print"},{"issue":"10","key":"ref57","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1345\/aph.1e212","article-title":"Celecoxib-induced methemoglobinemia","volume":"38","author":"Prashant Kaushik","year":"2004","journal-title":"Annals of Pharmacotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/1060-0280","issn-type":"print"},{"issue":"6","key":"ref58","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1046\/j.1526-4610.2002.02131.x","article-title":"Hemicrania Continua Responds to Cyclooxygenase-2 Inhibitors","volume":"42","author":"Mario F.P. Peres","year":"2002","journal-title":"Headache: The Journal of Head and Face Pain","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"issue":"9","key":"ref59","first-page":"834","article-title":"Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine","volume":"48","author":"H.J. Tan","year":"2007","journal-title":"Singapore Medical Journal"},{"issue":"3","key":"ref60","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10194-010-0194-3","article-title":"Focus on therapy: Hemicrania continua and new daily persistent headache","volume":"11","author":"Paolo Rossi","year":"2010","journal-title":"The journal of headache and pain","ISSN":"https:\/\/id.crossref.org\/issn\/1129-2369","issn-type":"print"},{"issue":"1","key":"ref61","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/head.12487","article-title":"Celecoxib vs prednisone for the treatment of withdrawal headache in patients with medication overuse headache: A randomized, double-blind clinical trial","volume":"55","author":"Foad Taghdiri","year":"2015","journal-title":"Headache: The Journal of Head and Face Pain","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"issue":"1","key":"ref62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/head.14024","article-title":"The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic-specific estimates from government health surveys","volume":"61","author":"Rebecca Burch","year":"2021","journal-title":"Headache: The Journal of Head and Face Pain","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"issue":"1","key":"ref63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/head.13663","article-title":"Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg\/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study","volume":"60","author":"Richard B. Lipton","year":"2020","journal-title":"Headache: The Journal of Head and Face Pain","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"issue":"11","key":"ref64","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41582-019-0255-4","article-title":"The metabolic face of migraine \u2014 from pathophysiology to treatment","volume":"15","author":"Elena C. Gross","year":"2019","journal-title":"Nature Reviews Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/1759-4758","issn-type":"print"},{"issue":"1","key":"ref65","first-page":"17","article-title":"Migraine headache prophylaxis","volume":"99","author":"H. Ha","year":"2019","journal-title":"American Family Physician"},{"issue":"1","key":"ref66","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/head.13663","article-title":"Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg\/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study","volume":"60","author":"Richard B. Lipton","year":"2020","journal-title":"Headache: The Journal of Head and Face Pain","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"issue":"1","key":"ref67","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/head.14024","article-title":"The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic-specific estimates from government health surveys","volume":"61","author":"Rebecca Burch","year":"2021","journal-title":"Headache: The Journal of Head and Face Pain","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"issue":"4","key":"ref68","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: Epidemiology, Burden, and Comorbidity","volume":"37","author":"Rebecca C. Burch","year":"2019","journal-title":"Neurologic Clinics","ISSN":"https:\/\/id.crossref.org\/issn\/0733-8619","issn-type":"print"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"111557","DOI":"10.1016\/j.biopha.2021.111557","article-title":"Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine","volume":"139","author":"Johra Khan","year":"2021","journal-title":"Biomedicine and Pharmacotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/0753-3322","issn-type":"print"}],"container-title":["Health Psychology Research"],"original-title":[],"link":[{"URL":"https:\/\/api.healthpr.org\/uploads\/file\/asp\/20250407114722a0c142910.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.healthpr.org\/uploads\/file\/asp\/20250407114722a0c142910.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T03:36:38Z","timestamp":1760412998000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthpr.org\/journal\/HPR\/10\/5\/10.52965\/001c.34265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":69,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,10,11]]}},"URL":"https:\/\/doi.org\/10.52965\/001c.34265","relation":{},"ISSN":["2420-8124"],"issn-type":[{"value":"2420-8124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]}}}